Volume-3 ~ Issue-6
- Citation
- Abstract
- Reference
- Full PDF
Abstract:Considerable controversy surrounds the formation of cooperative thrift and provision of transportation facilities undertaken by the maritime workers' union as means of improving members welfare. Our analysis of this study draws evidence from 1000 respondents. A self-constructed 45 item questionnaire on a four scale was used for data collection. Overall, findings reveals that a significant positive relationship exists between union's formation of cooperative societies and the provision of transportation facilities for union members. The study recommends that along with raising the welfare of its members which was found to be generally low, labour unions should rise to the responsibility of encouraging their members to join cooperative thrift and that union leaders should be credible individuals who seek the welfare of its members and not their personal interest.
[1] Adegete, A. J. (1999). Some observations in financing farmers cooperatives in developing countries. Nigeria Trade Journal, 25(6), 53 – 55.
[2] Adegeye S. O. (1940). The cooperative movement in Nigeria: Yesterday, today and tomorrow, Gottingen, Germany Vandenhoeck and Ruprecht.
[3] Adeniji, K. (1997). Factors in union transport (demand and supply): The Ogun State experience. Abeokuta: Ogun State University Press.
[4] Akpoghomeh, O. S. (2003). Transport: Developing analysis and planning. Port Harcourt: Man Printers.
[5] Eaton, J. (1999). The basque workers' cooperatives. Industry Relations Journal 10(3), 1 – 2.
[6] Gwillian, K. & Shalizi, (1996). Suitable transport, priorities for policy reform. Washington DC: The World Bank.
[7] Hann, J., Louter, K., & Gerald; G. (2003). Innovative behaviour in India cooperatives. New product development in traditional sectors. London: Longman.
[8] Irabor, O. (2006). Transportation and dockers productivity: A paper presented at dock labour employers conference. Nigerian Ports Authority. Port Harcourt. November 12.
[9] Klatzel, F. (2000). Green roads: Building environmentally, low maintenance rural roads through participation. http://www.
[10] mtnforum /resources/library/klatfooa.htm.
[2] Adegeye S. O. (1940). The cooperative movement in Nigeria: Yesterday, today and tomorrow, Gottingen, Germany Vandenhoeck and Ruprecht.
[3] Adeniji, K. (1997). Factors in union transport (demand and supply): The Ogun State experience. Abeokuta: Ogun State University Press.
[4] Akpoghomeh, O. S. (2003). Transport: Developing analysis and planning. Port Harcourt: Man Printers.
[5] Eaton, J. (1999). The basque workers' cooperatives. Industry Relations Journal 10(3), 1 – 2.
[6] Gwillian, K. & Shalizi, (1996). Suitable transport, priorities for policy reform. Washington DC: The World Bank.
[7] Hann, J., Louter, K., & Gerald; G. (2003). Innovative behaviour in India cooperatives. New product development in traditional sectors. London: Longman.
[8] Irabor, O. (2006). Transportation and dockers productivity: A paper presented at dock labour employers conference. Nigerian Ports Authority. Port Harcourt. November 12.
[9] Klatzel, F. (2000). Green roads: Building environmentally, low maintenance rural roads through participation. http://www.
[10] mtnforum /resources/library/klatfooa.htm.
- Citation
- Abstract
- Reference
- Full PDF
Abstract :The prevalence of type 2 diabetes mellitus has reached epidemic proportions worldwide.
Several single-nucleotide polymorphisms (SNPs) investigated in the genes of insulin signaling pathway have
been associated with type 2 diabetes. We investigated three single nucleotide polymorphisms at codon 233, 234
and 276 in exon 3 of insulin receptor gene in type 2 diabetic patients of Kashmir valley. 468 subjects
comprising of 198 type 2 diabetic cases and 270 non diabetic controls were included in the study. PCR-RFLP
technique was used for genotyping.Amplified products were digested withMspI, RsaI and FokI restriction
enzymes. Results were validated by direct sequencing of amplicons. All the subjects were monomorphic as no
genotypic or allelic variation was observed in either cases or controls. Our study elucidates that substitutions at
codon 233, 234 and 276 in exon 3 of insulin receptor gene do not occur in our population and thereby has no
role in conferring any risk or genetic predisposition towards development of type 2 diabetes..
Keyword: Insulin receptor, Kashmir valley, Single nucleotide polymorphism, Type 2 diabetes mellitus
Keyword: Insulin receptor, Kashmir valley, Single nucleotide polymorphism, Type 2 diabetes mellitus
[1] Y. Ebina, L. Ellis, K. Jarnagn, M.Edery, L. Graf, E. Clauser, J.H.Ou, F. Masiarz, Y. Kan, I. Goldfine, R. Roth, and W. Rutter, The
human insulin receptor cDNA,Cell40, 1985, 747-58.
[2] A. Ullrich, J.R.Bell, E.Y.Chen, R. Herrera, I.M.Petruzzelli, T.J. Dull, A. Gray, L. Coussens, Y.C.Lao, M. Tsubokawa, A. Mason,
P.H.Seeburg, C.Grunfeld, O.M. Rosen, and J. Ramachandran, Human insuln receptor and its relationship to the tyrosine kinase
famlly of oncogenes,Nature 313,1985, 756- 61.
[3] S. Seino, M. Seino, S. Nishi, and G. I.Bell, Structure of human insulin receptor gene and characterization of its
promoter,ProcNatlAcadSci USA 86, 1989,114-18.
[4] L.Elsas, N. Longo,S. Langley,L. Griffin,and R. Shuster, Molecular genetics of severe insulin resistance,Yale J Biol Med. 62(5),
1989,533-47.
[5] Y. Yarden, and A. Ullrich, Molecular analysis of signal transduction by growth factors,Biochemistry 27, 1988, 3113-19.
[6] Y. Yarden, and A. Ullrich, Growth factor receptor tyrosine kinases,Annu Rev Biochem. 57, 1988, 443-78.
[7] M. Gharbi, M. Akrout, and B. Zouari, Prevalence and risk factors of noninsulin- dependent diabetes mellitus in the rural and urban
population of Tunisia,Rev EpidemiolSantePublique. 503, 2002, 49–55.
[8] B.M.Vasarova de Courten, and R.L.Hanson, Higher prevalence of type 2 diabetes metabolic syndrome and cardiovascular diseases
in gypsies than in non-gypsies in Slovakia,Diabetes Res ClinPract.62, 2003,95–103.
[9] J. Sánchez-Corona, S. E.Flores-Martínez, and M. V. Machorro-Lazo, Polymorphisms in candidate genes for type 2 diabetes mellitus
in a Mexicanpopulation with metabolic syndrome findings,Diabetes Res ClinPrac.63, 2004,47–55.
[10] I. Arfa, A. Abid, and D. Malouche, Familial aggregation and excess maternal transmission of type 2 diabetes in Tunisia,Postgrad
Med J. 833, 2007, 48–51.
human insulin receptor cDNA,Cell40, 1985, 747-58.
[2] A. Ullrich, J.R.Bell, E.Y.Chen, R. Herrera, I.M.Petruzzelli, T.J. Dull, A. Gray, L. Coussens, Y.C.Lao, M. Tsubokawa, A. Mason,
P.H.Seeburg, C.Grunfeld, O.M. Rosen, and J. Ramachandran, Human insuln receptor and its relationship to the tyrosine kinase
famlly of oncogenes,Nature 313,1985, 756- 61.
[3] S. Seino, M. Seino, S. Nishi, and G. I.Bell, Structure of human insulin receptor gene and characterization of its
promoter,ProcNatlAcadSci USA 86, 1989,114-18.
[4] L.Elsas, N. Longo,S. Langley,L. Griffin,and R. Shuster, Molecular genetics of severe insulin resistance,Yale J Biol Med. 62(5),
1989,533-47.
[5] Y. Yarden, and A. Ullrich, Molecular analysis of signal transduction by growth factors,Biochemistry 27, 1988, 3113-19.
[6] Y. Yarden, and A. Ullrich, Growth factor receptor tyrosine kinases,Annu Rev Biochem. 57, 1988, 443-78.
[7] M. Gharbi, M. Akrout, and B. Zouari, Prevalence and risk factors of noninsulin- dependent diabetes mellitus in the rural and urban
population of Tunisia,Rev EpidemiolSantePublique. 503, 2002, 49–55.
[8] B.M.Vasarova de Courten, and R.L.Hanson, Higher prevalence of type 2 diabetes metabolic syndrome and cardiovascular diseases
in gypsies than in non-gypsies in Slovakia,Diabetes Res ClinPract.62, 2003,95–103.
[9] J. Sánchez-Corona, S. E.Flores-Martínez, and M. V. Machorro-Lazo, Polymorphisms in candidate genes for type 2 diabetes mellitus
in a Mexicanpopulation with metabolic syndrome findings,Diabetes Res ClinPrac.63, 2004,47–55.
[10] I. Arfa, A. Abid, and D. Malouche, Familial aggregation and excess maternal transmission of type 2 diabetes in Tunisia,Postgrad
Med J. 833, 2007, 48–51.
- Citation
- Abstract
- Reference
- Full PDF
Abstract:Methicillin resistant Staphylococcus aureus (MRSA) has emerged as a community acquired infection
in the past decade. Molecular studies showed that HCA-MRSA and CA-MRSA represent different organisms
that produced different clinical syndromes .MRSA infection is associated with high morbidity, mortality, longer
hospital stay and economic burden worldwide. All over the world, the dissemination of a few distinct clones of
CA-MRSA has resulted in an increase in skin and soft tissue infections and necrotizing pneumonia, without
defined risk factors. There has been link to fluroquinolone (FQ) exposure to epidemic CA-MRSA strains
obtained from subjects with nasal colonization. Low socioeconomic status may be one common link among the
identified high-risk groups, although many patients with CA-MRSA infections have no risk factor. CA-MRSA
isolates are characterized by the presence of SCCmec type IV or type V. S.aureus clones ST30, ST80, CC75 and
ST 93 has been documented in some countries. These clones are likely to provide insights into the emergence of
methicillin resistant strains of S.aureus. CA-MRSA is readily disseminated in the hospitals and may cause
outbreaks of infection .It is suggested that the use of the few effective antibiotic agent should be restricted
.Despite these measures, the spread of this organism may not be contained.
Key Words:MRSA, CA-MRSA, HCA-MRSA, S.aureus.
Key Words:MRSA, CA-MRSA, HCA-MRSA, S.aureus.
[1] Bilroh T.Unterusuchungen iiber die Vegetationsformen von coccobacteria septica. Berlin, Reimer, 1874; 244.
[2] Ogston A .Micrococcus poisoning. J anat Physiol (London) 1883; 17:24-58.
[3] Jevons MP."Celbenin" resistant Staphylococcus.Br Med J.1961; 1:124-125.
[4] Panililo Al ,Culver DH, Gaynes RP ,et al ,Methicillin-resistant Staphylococcus aureus in U.S. hospitals,1975-191,Infect Control
Hosp Epidemiol,1992;13:582-586.
[5] Styers D ,Sheehan DJ ,Hogan P, Sahm DF .Laboratory-based surveillance of current antimicrobial resistance patterns and trends
among Staphylococcus aureus : 2005 status in the United States. Ann Clin Microbiol Antimicrob.2006; 5:2.
[6] Diekema DJ, P faller MA ,Schmitz FJ ,et al .Survey of infections due to Staphylococcus species: frequency of occurrence
antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe ,and the Western Pacific
region for the SENTRY Antimicrobial Surveillance Program,977-1999.Clin Infect Dis.2001;32:5114-5132.
[7] McGowan J .Antibiotic resistance in hospital organisms and its relation to antibiotic use, Rev Infect Dis, 1983; 5:1033-48
[8] Dufour P, Gillette Y, Bes M, et al. Community acquired methicillin resistant Staphylococcus aureus infections in France:
emergence of a. clone that produces Pantong Valentine leukocidin .Clin Infect Dis.2002;35:819-824.
[9] Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S.aureus Infections among patients in the emergency
department .N.Engl J Med.2006;355:666-674
[10] Dietrich DW, Auld D, Mermel LA .Community-acquired methicillin-resistant Staphylococcus aureus in Southern New England
Children.Pediatrics.2004; 113:e347e352
[2] Ogston A .Micrococcus poisoning. J anat Physiol (London) 1883; 17:24-58.
[3] Jevons MP."Celbenin" resistant Staphylococcus.Br Med J.1961; 1:124-125.
[4] Panililo Al ,Culver DH, Gaynes RP ,et al ,Methicillin-resistant Staphylococcus aureus in U.S. hospitals,1975-191,Infect Control
Hosp Epidemiol,1992;13:582-586.
[5] Styers D ,Sheehan DJ ,Hogan P, Sahm DF .Laboratory-based surveillance of current antimicrobial resistance patterns and trends
among Staphylococcus aureus : 2005 status in the United States. Ann Clin Microbiol Antimicrob.2006; 5:2.
[6] Diekema DJ, P faller MA ,Schmitz FJ ,et al .Survey of infections due to Staphylococcus species: frequency of occurrence
antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe ,and the Western Pacific
region for the SENTRY Antimicrobial Surveillance Program,977-1999.Clin Infect Dis.2001;32:5114-5132.
[7] McGowan J .Antibiotic resistance in hospital organisms and its relation to antibiotic use, Rev Infect Dis, 1983; 5:1033-48
[8] Dufour P, Gillette Y, Bes M, et al. Community acquired methicillin resistant Staphylococcus aureus infections in France:
emergence of a. clone that produces Pantong Valentine leukocidin .Clin Infect Dis.2002;35:819-824.
[9] Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S.aureus Infections among patients in the emergency
department .N.Engl J Med.2006;355:666-674
[10] Dietrich DW, Auld D, Mermel LA .Community-acquired methicillin-resistant Staphylococcus aureus in Southern New England
Children.Pediatrics.2004; 113:e347e352
- Citation
- Abstract
- Reference
- Full PDF
Abstract:Research Question:-What is the level of knowledge & practices regarding prevention of Dengue
fever among the JHWs?
Objectives of the Study were: -
1. To assess the knowledge of JHWs regarding cause, spread and prevention of dengue fever.
2. To identify the practices towards preventive measures in dengue fever among the JHWs.
3. To find out the association between the sociodemographic variables of JHW's And level of knowledge
regarding dengue.
4. To find out the association between knowledge and practices towards Prevention of dengue fever among
the JHWs.
Participants:
Purposely selected 95 JHWs between 19-58yrs age group of both sex working under the PHC's of
Belgaum Taluka.
[1] Park K. Text book of preventive and social medicine. 19th ed. Jabalpur. M/s.Banarasidas Bhanot Publishers, Jabalpur, 2007: 28, 206
– 209, 534, 685.
[2] Satyanarayan K. Emerging infectious diseases in South East Asia; Research Priorities. ICMR Bulletin 2004. May- June; 34 (5-6):
30
[3] Rao BS. Principles of community Medicine. 4th Ed. New Delhi. AITBS Publications, 2005; 352-355.
[4] Gulani K.K. Community Health Nursing- Principles and Practices. 1st ed. New Delhi. Kumar Publishing House 2004; 49, 545.
[5] Galleges De Hernandez et. al., WHO study group on Community Health Workers. Geneva. Dec. 87; 4- 13.
[6] Kulkarni A.P., Baride. Textbook of community Medicine. 2nd education year 442 publication.
[7] Department of Community and Social Medicine. Mac. Sot Gen. Hospital Thailand. South East. Asian. J Trop. Med Public Health.
1992. Jun.: 23 (2) : 207 –
[8] Sebastian Ousepparampil. Strengthening the health workforce. Health Action 2006 Apr. 19 (4): 1 – 14.
[9] Barzgar MA, Shaikh MR and Bile MK. Female health workers boost primary are world health forum 1997; 18 : 202 – 9.
– 209, 534, 685.
[2] Satyanarayan K. Emerging infectious diseases in South East Asia; Research Priorities. ICMR Bulletin 2004. May- June; 34 (5-6):
30
[3] Rao BS. Principles of community Medicine. 4th Ed. New Delhi. AITBS Publications, 2005; 352-355.
[4] Gulani K.K. Community Health Nursing- Principles and Practices. 1st ed. New Delhi. Kumar Publishing House 2004; 49, 545.
[5] Galleges De Hernandez et. al., WHO study group on Community Health Workers. Geneva. Dec. 87; 4- 13.
[6] Kulkarni A.P., Baride. Textbook of community Medicine. 2nd education year 442 publication.
[7] Department of Community and Social Medicine. Mac. Sot Gen. Hospital Thailand. South East. Asian. J Trop. Med Public Health.
1992. Jun.: 23 (2) : 207 –
[8] Sebastian Ousepparampil. Strengthening the health workforce. Health Action 2006 Apr. 19 (4): 1 – 14.
[9] Barzgar MA, Shaikh MR and Bile MK. Female health workers boost primary are world health forum 1997; 18 : 202 – 9.
- Citation
- Abstract
- Reference
- Full PDF
Abstract:Access of adult insects to food supplement will affect the intrinsic life history traits. Artificial diets
are important for mass culture of insects for research and other purposes. Therefore, the effects of sugar diet on
the aspect of longevity of adults, fecundity of female and hatchability of eggs of cocoa moth, Ephestia cautella
W. (Lepidoptera: Pyralidae) were investigated in the laboratory at ambient temperature 27 ± 2ºC, 70± 5%
relative humidity and 12:12 hour photoperiod). Prior to mating, homogenous cultures of E. cautella reared on
cocoa powder artificial diet were exposed to: water without sugar (WWS), sugar solution at 5% –Sa, sugar
sugar at 10% –Sb and no water, no sugar (NSNW)- control. The result showed a significant increase (P > 0.05)
in the pre-oviposition period of Sa (3.17±1.80) > Sb (2.42±1.18) > WWS (2.08±0.79) > NSNW (1.75±0.75). The
incubation period was 4.7days, 4.0 days and 4.6 days and 3.2 days in NWNS, WWS, Sa and Sb respectively.
Fecundity ranged between 21.95 ± 7.82 in mated male X mated female to 131.05 ± 31.73 in virgin female
treated to 10% sugar solution X virgin male without treatment. Female longevity significantly reduced in virgin
female with 10% sugar solution (3.30 ± 0.24 days) than in virgin female without treatments (7.40 ± 0.17 days)
and mated female treated to 5% sugar solution (7.40 ± 0.21 days). However, there was no significant difference
(P > 0.05) in the longevity of virgin male without treatments (9.75 ± 0.23 days), mated male without treatments
(9.00 ± 0.10 days) and virgin males treated to 5% sugar solution (9.45 ± 0.71 days). Diets and other
supplements can be modified so as to suppress and/or improve the intrinsic life history traits in insects, which
can be harnessed in mass rearing of insects, as well as a non- chemical technique in pest management.
Key Words:Artificial diets; Ephestia cautella; Fecundity; Life history; Longevity; Preoviposition.
Key Words:Artificial diets; Ephestia cautella; Fecundity; Life history; Longevity; Preoviposition.
[1] J.M. Abreu and R.N. Williams, Monitoring Ephestia cautella in Brazilian cocoa warehouse with natural and synthetic pheromones,
Rev. Theobroma, 10(4): 187-192.
[2] P.A. Cook and M.J.G Gage, Effects of risks of sperm competition on the numbers of eupyrene and apyrene sperm ejaculated by the
moth plodia interpunctella (Lepidoptera; pyralidae), Behavioural Ecology and Sociobiology, 36, 1995, 261-268.
[3] M.J. Norris (Contribution towards the study of insect fertility III). Adult nutrition, fecundity and longevity in genus Ephestia
(Lepidoptera; Phycitidae): proc. of the Zoological Society of London 1-2, 1934, 333-360.
[4] J.F. Benson: The Biology of Lepidoptera infesting stored products, with special reference to population dynamics, Biological
Reviews, 48, 1973, 1-26.
[5] C. Ryne, P.A. Nilsson and M.T. Silva- Jothy, Dietary glycerol and adult access to water: effects on fecundity and longevity in
almost moth, Journal of Insect Physiology, 50, 2004, 429-434.
[6] D.A. Roff, Life History Evolution (Sinaver Assocaites) Inc., 2002.
[7] Y.S. Chow, D.F. Yen and S.H. Lin, Water, a powerful attractant for the gravid females of plodia interpunctella and Cadre cautella,
Experentia, 4, 1997, 453-455.
[8] C. Ryne, M. Ekeberg, P. Olsson, O.C. Valour and C. Lofstedt, Water revisited: a powerful attractant for certain stored-product
moths, Entomologia Experimentalis et Applicata, 103, 2002, 99-103.
[9] M.H.G. Gage, Influences of sex, size and symmetry on ejaculate expenditure in a moth, Behavioural Ecology, 9, 1998, 592-597.
[10] P.A. Cook, Sperm numbers and female fertility in the moth Plodia interpunctella (Hubner) (Lepidoptera; Pyralidae), Journal of
Insect Behaviour, 12, 1999, 767-779.
Rev. Theobroma, 10(4): 187-192.
[2] P.A. Cook and M.J.G Gage, Effects of risks of sperm competition on the numbers of eupyrene and apyrene sperm ejaculated by the
moth plodia interpunctella (Lepidoptera; pyralidae), Behavioural Ecology and Sociobiology, 36, 1995, 261-268.
[3] M.J. Norris (Contribution towards the study of insect fertility III). Adult nutrition, fecundity and longevity in genus Ephestia
(Lepidoptera; Phycitidae): proc. of the Zoological Society of London 1-2, 1934, 333-360.
[4] J.F. Benson: The Biology of Lepidoptera infesting stored products, with special reference to population dynamics, Biological
Reviews, 48, 1973, 1-26.
[5] C. Ryne, P.A. Nilsson and M.T. Silva- Jothy, Dietary glycerol and adult access to water: effects on fecundity and longevity in
almost moth, Journal of Insect Physiology, 50, 2004, 429-434.
[6] D.A. Roff, Life History Evolution (Sinaver Assocaites) Inc., 2002.
[7] Y.S. Chow, D.F. Yen and S.H. Lin, Water, a powerful attractant for the gravid females of plodia interpunctella and Cadre cautella,
Experentia, 4, 1997, 453-455.
[8] C. Ryne, M. Ekeberg, P. Olsson, O.C. Valour and C. Lofstedt, Water revisited: a powerful attractant for certain stored-product
moths, Entomologia Experimentalis et Applicata, 103, 2002, 99-103.
[9] M.H.G. Gage, Influences of sex, size and symmetry on ejaculate expenditure in a moth, Behavioural Ecology, 9, 1998, 592-597.
[10] P.A. Cook, Sperm numbers and female fertility in the moth Plodia interpunctella (Hubner) (Lepidoptera; Pyralidae), Journal of
Insect Behaviour, 12, 1999, 767-779.
- Citation
- Abstract
- Reference
- Full PDF
Abstract:This investigation aims at comparing starches from two grains: Maize (Zea mays) and Sweet potato
(Ipomoea batatas) grains. These grains are used mainly as foods and they contain high amount of carbohydrate.
The presence of starch in these grains varies and thus their use as pharmaceutical excipients will vary to the
degree of their starch functionality. The powders obtained were characterized for their particle size, particle
size distribution. The organoleptic and physicochemical characterization such as viscosity, hydration capacity,
swelling capacity, moisture sorption capacity, pH, flow rate and porosity, Carr's index and Hausner's ratio
were evaluated. Maize starch showed the least Carr's index, Hausner ratio, porosity, moisture sorption capacity
and the greatest flow rate. Sweet potato starch showed the highest hydration capacity and swelling capacity.
The results obtained showed that between the two starches in relation to their flowability, maize starch
possesses the best flow property. Compatibility of Etoricoxib with maize and sweet potato starch was evaluated
by IR spectra and found that both Etoricoxib is compatible along with maize and sweet potato starch. This
knowledge of starch properties will help to explain the behavior of these starches when used as tablet
excipients.
Key Words:Starch, Carbohydrate, Flow ability, Etoricoxib.
Key Words:Starch, Carbohydrate, Flow ability, Etoricoxib.
[1] Picker KM. 2004. Soft tableting: a new concept to tablet pressure sensitive drugs. Pharm. Dev. Technol.9:107-121.
[2] Hauschild K, Picker KM. 2004. Evaluation of a new compressed compound based on lactose and maize starch for tablet
formulation. AAPS Pharm Sci. 6:1-12.
[3] Zhang Y, Law Y, Chakrabarti S. 2003. Physical properties and compact analysis of commonly used direct compression binders.
AAPS Pharm Sci. 4:1-11.
[4] Heinemann C, Cardinaux F, Scheffold F, Schurtenberger P, Escher F, Conde-Petit B. 2004. Tracer micro rheology of γ-
dodecalactone induced gelation of aqueous starch dispersions. Carbohydr. Polym. 55:155-161.
[5] Baldwin PM. 2001. Starch-granule associated proteins and polypeptides: a review. Starch/ Stärke. 53:475-503.
[6] Swinkels JJ. 1985. Compositions and properties of commercial native starches. Starch/ Stärke. 37:1-5.
[7] Parrott EL.1990. Compression. In: Augsburger LL, Hoag SW,eds. Pharmaceutical Dosage Forms: Tablets. New York, USA:
Marcel Dekker, Inc., pp: 153-182.
[8] Rudnic EM, Kottke MK. 2002. Tablet dosage forms. In: Banker GS, and Rhodes C, eds. Modern Pharmaceutics, New York, USA:
Marcel Dekker, Inc. pp: 333-391.
[9] Ghani A. 2003. Medicinal plants of Bangladesh. 2nd Edition. The Asiatic Society of Bangladesh, Dhaka, Bangladesh.
[10] Iwuagwu MA, Okoli PC. 1992. The disintegrant properties of pregelatinized cassava and white yam starch. Pharm. World J. 9: 49
– 53.
[2] Hauschild K, Picker KM. 2004. Evaluation of a new compressed compound based on lactose and maize starch for tablet
formulation. AAPS Pharm Sci. 6:1-12.
[3] Zhang Y, Law Y, Chakrabarti S. 2003. Physical properties and compact analysis of commonly used direct compression binders.
AAPS Pharm Sci. 4:1-11.
[4] Heinemann C, Cardinaux F, Scheffold F, Schurtenberger P, Escher F, Conde-Petit B. 2004. Tracer micro rheology of γ-
dodecalactone induced gelation of aqueous starch dispersions. Carbohydr. Polym. 55:155-161.
[5] Baldwin PM. 2001. Starch-granule associated proteins and polypeptides: a review. Starch/ Stärke. 53:475-503.
[6] Swinkels JJ. 1985. Compositions and properties of commercial native starches. Starch/ Stärke. 37:1-5.
[7] Parrott EL.1990. Compression. In: Augsburger LL, Hoag SW,eds. Pharmaceutical Dosage Forms: Tablets. New York, USA:
Marcel Dekker, Inc., pp: 153-182.
[8] Rudnic EM, Kottke MK. 2002. Tablet dosage forms. In: Banker GS, and Rhodes C, eds. Modern Pharmaceutics, New York, USA:
Marcel Dekker, Inc. pp: 333-391.
[9] Ghani A. 2003. Medicinal plants of Bangladesh. 2nd Edition. The Asiatic Society of Bangladesh, Dhaka, Bangladesh.
[10] Iwuagwu MA, Okoli PC. 1992. The disintegrant properties of pregelatinized cassava and white yam starch. Pharm. World J. 9: 49
– 53.
- Citation
- Abstract
- Reference
- Full PDF
Paper Type | : | Research Paper |
Title | : | Biological control of bloody diarrhea by using recombinant bacterial ghost system |
Country | : | Iraq |
Authors | : | Shayma`a Jamal Ahmed Nawfal K.Yas |
: | 10.9790/3008-0363740 |
Abstract:Diarrhea is the most common illness affecting human. It is defined as passing three or more unformed stools in 24 hours. The most common causes of diarrhea include the following: Bacterial infections, viral infections, parasites, functional bowel disorders, intestinal diseases, food intolerance, sensitivities and reaction to medicines. People who visit certain foreign countries are at risk for traveler's diarrhea (TD). Bacterial ghosts are empty cells with intact envelopes, they have a natural outer surface make-up which provides them with the original targeting functions of the pathogen they are derived from and are thus able to induce strong local immunity, ghost are produced by controlled expression of cloned bactriophage phi x 174 lysis gene.
Key Words:Diarrhea, ghost delivery system, Salmonella typhi Ty21a.
Key Words:Diarrhea, ghost delivery system, Salmonella typhi Ty21a.
1] Ahmed SH.J.(1997). The transfer of genetic and immune-determinant to, and genetic improvement of Salmonella typhi strain used as oral vaccine.(M.Sc. thesis). College of Science. Baghdad Unversity.
[2] Ahmed SH.J.,Al-zaag A.A.& Ali N.A.(2001). A modified Salmonella typhi strain suitable as oral vaccine against Escherichia coli and typhoid infections. J. Fac. Med. 43(1) 77-80.
[3] DuPont H.L.(1997).Practice parameters committee of American college of Gastroenterology.Guidelines on acute infectious diarrhea in adults.The American J. of Gastroenterology. 92 (11). 1962-75 .
[4] Jechlinger W.,Szostak M.P., Witte, A.& Lubitz, W.(1999). Altered temperature induction sensitivity of the Lambda pR/CI857 system for controlled gene E. in expression in Escherichia coli . FEMS Microbiology letters. 173. 347-52.
[5] Käppeli U.,Hächler H., Giezendanner N., Beutin L.& Stephan R.(2011). Human Infections with Non-o157 Shiga Toxin-producing Escherichia coli , Switerland, 2000-2009. Emerging Infectious Diseases.17(2).180-85.
[6] Lubitz W.A., Witte F., Eko M., Kamal W., Jechlinger E.,Brand J., Marchart W., Haidinger V., Huter D., Felnerova N. et al. (1999). Extended recombinant bacterial ghost System.J. Biotechnol. 73. 261-73.
[7] Oconnell M.P.(1984). Genetic transfer in prokaryotes: Transformation, Transduction and conjugation.pp.2-13. In Puhler A.& Timmis K.N.(eds.). Advanced Molecular Genetics. Springer Verlag. Berlin.
[8] Ramaswamy K., Jacobson K.(2001). Infectious diarrhea in children. Gastroenterology clinics of North America.30(3).611-
[9] Sambrook J., Fritsoh E.F & Manaitis T.( 1989) Molecular cloning: A laboratory manual 2nd edition.
[10] SchÖn P., Schrot G., Wanner G., Lubitz w.& Witte A.(1995). Two-stage model for integration of the lysis protein E of bacteriophage phiX174 into cell envelope of E.coli .FEMS Microbiol. Rev.17.207-12.
[2] Ahmed SH.J.,Al-zaag A.A.& Ali N.A.(2001). A modified Salmonella typhi strain suitable as oral vaccine against Escherichia coli and typhoid infections. J. Fac. Med. 43(1) 77-80.
[3] DuPont H.L.(1997).Practice parameters committee of American college of Gastroenterology.Guidelines on acute infectious diarrhea in adults.The American J. of Gastroenterology. 92 (11). 1962-75 .
[4] Jechlinger W.,Szostak M.P., Witte, A.& Lubitz, W.(1999). Altered temperature induction sensitivity of the Lambda pR/CI857 system for controlled gene E. in expression in Escherichia coli . FEMS Microbiology letters. 173. 347-52.
[5] Käppeli U.,Hächler H., Giezendanner N., Beutin L.& Stephan R.(2011). Human Infections with Non-o157 Shiga Toxin-producing Escherichia coli , Switerland, 2000-2009. Emerging Infectious Diseases.17(2).180-85.
[6] Lubitz W.A., Witte F., Eko M., Kamal W., Jechlinger E.,Brand J., Marchart W., Haidinger V., Huter D., Felnerova N. et al. (1999). Extended recombinant bacterial ghost System.J. Biotechnol. 73. 261-73.
[7] Oconnell M.P.(1984). Genetic transfer in prokaryotes: Transformation, Transduction and conjugation.pp.2-13. In Puhler A.& Timmis K.N.(eds.). Advanced Molecular Genetics. Springer Verlag. Berlin.
[8] Ramaswamy K., Jacobson K.(2001). Infectious diarrhea in children. Gastroenterology clinics of North America.30(3).611-
[9] Sambrook J., Fritsoh E.F & Manaitis T.( 1989) Molecular cloning: A laboratory manual 2nd edition.
[10] SchÖn P., Schrot G., Wanner G., Lubitz w.& Witte A.(1995). Two-stage model for integration of the lysis protein E of bacteriophage phiX174 into cell envelope of E.coli .FEMS Microbiol. Rev.17.207-12.
- Citation
- Abstract
- Reference
- Full PDF
Abstract:Hepatitis B is a serious health risk nowadays and needs advancement in its treatment against increasing problems of fewer efficacies of drugs and the existence of resistant mutants of hepatitis B virus (HBV). In the present study the problem of designing an anti-Hepatitis B drug with more efficacies was solved by using computer aided drug designing (CADD). Docking of 30 selected ligands, comprised of active drugs for hepatitis B and compounds having anti-Hepatitis B activity, was done with the active site of protein GIPC2 and a lead compound was recognized on the basis of hydrogen bonding, hydrophobic and ionic interactions. A Quantitative structure activity relationship of selected 30 compounds was also performed in which electronic and steric descriptors were calculated and correlated with the bioactivity (IC50) of the drugs. Three analogs of the lead compound were designed to enhance its activity against hepatitis B virus (HBV). Analogs were docked with protein GIPC2 and their interactions showed that they could possess good inhibitory activity against HBV with suitable drug-like properties as compared to other active drugs for hepatitis B and therefore could be recommended for further studies.
Key Words:Analog, anti-hepatitis B drugs, antiviral agents, anti HBV drugs, computer aided drug design, IC50, molecular docking, lead compound, QSAR
Key Words:Analog, anti-hepatitis B drugs, antiviral agents, anti HBV drugs, computer aided drug design, IC50, molecular docking, lead compound, QSAR
[1] W. Jia, Y. Liu, W. Li, Y. Liu, D. Zhang, P. Zhang and P. Gong, Synthesis and in vitro anti-hepatitis B virus activity of 6H-[1]benzothiopyrano[4,3-b]quinolin-9-ols,Bioorganic & Medicinal Chemistry, 17, 2009, pp. 4569–4574.
[2] G.L. Colombo, G.B. Gaeta, M. Vigano and S.D. Matteo, A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy, Clinico Economics and Outcomes Research, 3, 2011, pp. 37–46.
[3] M. Ali, M. Idrees, L. Ali, A. Hussain, I.U. Rehman, S. Saleem, S. Afzal and S. Butt, Hepatitis B virus in Pakistan: A systematic review of prevalence, risk factors, awareness status and genotypes, Virology Journal, 8, 2011, pp. 102.
[4] D. Ganem and A.M. Prince, Mechanisms of disease: Hepatitis B virus infection—Natural history and clinical consequences, N. Engl. J. Med., 350, 2004, pp. 1118–1129.
[5] A. Ascherio, S.M. Zhang, M.A. Hernan, M.J. Olek, P.M. Coplan, K. Brodovicz and A.M. Walker, Hepatitis B vaccination and the risk of multiple sclerosis, N. Engl. J. Med., 344, 2011, pp. 327–332.
[6] H. Kwon and A.S. Lok, Hepatitis B therapy, Nat. Rev. Gastroenterol. Hepatol, 8, 2011, pp. 275–284.
[7] S.B. Robert, Long-term data on current treatments for chronic hepatitis B, Gastroenterology &Hepatology, 7, 2011, pp. 3.
[8] G.V. Papatheodoridis, Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues, Liver International, 31, 2011, pp. 95–103. [9] C.M. Song, S.J. Lim and J.C. Tong, Recent advances in computer-aided drug design, Briefings in Bioinformatics Advance Access, 10, 2009, pp. 579–591.
[10] J.S. Bader and D. Chandler, Computer simulation study of the mean forces between ferrous and ferric ions in water, Phys. Chem. 96, 1992, pp. 6423–6427.
[2] G.L. Colombo, G.B. Gaeta, M. Vigano and S.D. Matteo, A cost-effectiveness analysis of different therapies in patients with chronic hepatitis B in Italy, Clinico Economics and Outcomes Research, 3, 2011, pp. 37–46.
[3] M. Ali, M. Idrees, L. Ali, A. Hussain, I.U. Rehman, S. Saleem, S. Afzal and S. Butt, Hepatitis B virus in Pakistan: A systematic review of prevalence, risk factors, awareness status and genotypes, Virology Journal, 8, 2011, pp. 102.
[4] D. Ganem and A.M. Prince, Mechanisms of disease: Hepatitis B virus infection—Natural history and clinical consequences, N. Engl. J. Med., 350, 2004, pp. 1118–1129.
[5] A. Ascherio, S.M. Zhang, M.A. Hernan, M.J. Olek, P.M. Coplan, K. Brodovicz and A.M. Walker, Hepatitis B vaccination and the risk of multiple sclerosis, N. Engl. J. Med., 344, 2011, pp. 327–332.
[6] H. Kwon and A.S. Lok, Hepatitis B therapy, Nat. Rev. Gastroenterol. Hepatol, 8, 2011, pp. 275–284.
[7] S.B. Robert, Long-term data on current treatments for chronic hepatitis B, Gastroenterology &Hepatology, 7, 2011, pp. 3.
[8] G.V. Papatheodoridis, Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues, Liver International, 31, 2011, pp. 95–103. [9] C.M. Song, S.J. Lim and J.C. Tong, Recent advances in computer-aided drug design, Briefings in Bioinformatics Advance Access, 10, 2009, pp. 579–591.
[10] J.S. Bader and D. Chandler, Computer simulation study of the mean forces between ferrous and ferric ions in water, Phys. Chem. 96, 1992, pp. 6423–6427.